Conaghan, P. G., Durez, P., Alten, R. E., Burmester, G., Tak, P. P., Klareskog, L., . . . Peterfy, C. (2013). Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: The ASSET randomised controlled trial. BMJ Publishing Group.
Chicago Style CitationConaghan, Philip G., et al. Impact of Intravenous Abatacept On Synovitis, Osteitis and Structural Damage in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: The ASSET Randomised Controlled Trial. BMJ Publishing Group, 2013.
Cita MLAConaghan, Philip G., et al. Impact of Intravenous Abatacept On Synovitis, Osteitis and Structural Damage in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: The ASSET Randomised Controlled Trial. BMJ Publishing Group, 2013.